You are here »
Home »
Company » Glaxosmithkline Pharmaceuticals Ltd
Glaxosmithkline Pharmaceuticals Ltd.
BSE: 500660 |
Sector: Health care |
NSE: GLAXO |
ISIN Code: INE159A01016 |
BSE
00:00 | 26 Feb
|
1460.70
|
-11.40 (-0.77%)
|
OPEN
1473.95
|
HIGH
1474.00
|
LOW
1451.10
|
NSE
00:00 | 26 Feb
|
1460.55
|
-14.15 (-0.96%)
|
OPEN
1474.00
|
HIGH
1475.00
|
LOW
1455.50
|
OPEN |
1473.95 |
PREVIOUS CLOSE |
1472.10 |
VOLUME |
1780 |
52-Week high |
1805.00 |
52-Week low |
1046.40 |
P/E |
48.87 |
Mkt Cap.(Rs cr) |
24,746 |
Buy Price |
1452.00 |
Buy Qty |
1.00 |
Sell Price |
1460.70 |
Sell Qty |
13.00 |
OPEN |
1474.00 |
PREVIOUS CLOSE |
1474.70 |
VOLUME |
30860 |
52-Week high |
1807.50 |
52-Week low |
962.65 |
P/E |
48.87 |
Mkt Cap.(Rs cr) |
24,746 |
Buy Price |
0.00 |
Buy Qty |
0.00 |
Sell Price |
1460.55 |
Sell Qty |
1830.00 |
OPEN |
1473.95 |
CLOSE |
1472.10 |
VOLUME |
1780 |
52-Week high |
1805.00 |
52-Week low |
1046.40 |
P/E |
48.87 |
Mkt Cap.(Rs cr) |
24,746 |
Buy Price |
1452.00 |
Buy Qty |
1.00 |
Sell Price |
1460.70 |
Sell Qty |
13.00 |
OPEN |
1474.00 |
PREVIOUS CLOSE |
1474.70 |
VOLUME |
30860 |
52-Week high |
1807.50 |
52-Week low |
962.65 |
P/E |
48.87 |
Mkt Cap.(Rs cr) |
24745.72 |
Buy Price |
0.00 |
Buy Qty |
0.00 |
Sell Price |
1460.55 |
Sell Qty |
1830.00 |
About Glaxosmithkline Pharmaceuticals Ltd.
Glaxosmithkline Pharmaceuticals Ltd
GlaxoSmithKline Pharmaceuticals Ltd is one of the leading pharmaceutical companies in the India. It is a subsidiary of GlaxoSmithKline plc UK one of the world's leading research-based pharmaceutical and healthcare companies. The company's product portfolio includes prescription medicines and vaccines. Their prescription medicines range across therapeutic areas such as anti-infectives dermatology g...> More
Glaxosmithkline Pharmaceuticals Ltd - Key Fundamentals
Glaxosmithkline Pharmaceuticals Ltd - Financial Results
Particulars ( cr) |
Dec 2020 |
Dec 2019 |
% Chg |
Net Sales |
857.2 |
778.59 |
10.1 |
Other Income |
24.55 |
16.5 |
48.79 |
Total Income |
881.75 |
795.09 |
10.9 |
Total Expenses |
651.69 |
1408.1 |
-53.72 |
Operating Profit |
230.06 |
-613.01 |
137.53 |
Net Profit |
156.51 |
-661.16 |
123.67 |
Equity Capital |
169.41 |
169.41 |
- |
> More on Glaxosmithkline Pharmaceuticals Ltd Financials Results
Glaxosmithkline Pharmaceuticals Ltd - Peer Group
Glaxosmithkline Pharmaceuticals Ltd - SHAREHOLDING PATTERN
Glaxosmithkline Pharmaceuticals Ltd - Research Reports
Glaxosmithkline Pharmaceuticals Ltd - RETURNS
Period |
BSE |
NSE |
Sensex |
NIFTY |
1 Week |
0.70% |
0.68% |
-3.52% |
-3.02% |
1 Month |
-1.89% |
-1.84% |
1.56% |
2.04% |
3 Month |
-5.18% |
-5.17% |
10.94% |
11.87% |
6 Month |
-8.02% |
-8.11% |
25.66% |
25.80% |
1 Year |
7.88% |
7.71% |
23.09% |
24.41% |
3 Year |
21.85% |
21.29% |
42.54% |
37.29% |
Glaxosmithkline Pharmaceuticals Ltd - STOCK STRENGTH
Today's Low/High |
1451.10 |
|
1474.00 |
Week Low/High |
1406.30 |
|
1482.00 |
Month Low/High |
1406.30 |
|
1549.00 |
YEAR Low/High |
1046.40 |
|
1805.00 |
All TIME Low/High |
12.88 |
|
1925.00 |
Quick Links for Glaxosmithkline Pharmaceuticals: